Literature DB >> 23369974

Reliability and validity of heart rate variability threshold assessment during an incremental shuttle-walk test in middle-aged and older adults.

V Z Dourado1, R L F Guerra.   

Abstract

Studies on the assessment of heart rate variability threshold (HRVT) during walking are scarce. We determined the reliability and validity of HRVT assessment during the incremental shuttle walk test (ISWT) in healthy subjects. Thirty-one participants aged 57 ± 9 years (17 females) performed 3 ISWTs. During the 1st and 2nd ISWTs, instantaneous heart rate variability was calculated every 30 s and HRVT was measured. Walking velocity at HRVT in these tests (WV-HRVT1 and WV-HRVT2) was registered. During the 3rd ISWT, physiological responses were assessed. The ventilatory equivalents were used to determine ventilatory threshold (VT) and the WV at VT (WV-VT) was recorded. The difference between WV-HRVT1 and WV-HRVT2 was not statistically significant (median and interquartile range = 4.8; 4.8 to 5.4 vs 4.8; 4.2 to 5.4 km/h); the correlation between WV-HRVT1 and WV-HRVT2 was significant (r = 0.84); the intraclass correlation coefficient was high (0.92; 0.82 to 0.96), and the agreement was acceptable (-0.08 km/h; -0.92 to 0.87). The difference between WV-VT and WV-HRVT2 was not statistically significant (4.8; 4.8 to 5.4 vs 4.8; 4.2 to 5.4 km/h) and the agreement was acceptable (0.04 km/h; -1.28 to 1.36). HRVT assessment during walking is a reliable measure and permits the estimation of VT in adults. We suggest the use of the ISWT for the assessment of exercise capacity in middle-aged and older adults.

Entities:  

Mesh:

Year:  2013        PMID: 23369974      PMCID: PMC3854360          DOI: 10.1590/1414-431x20122376

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


Introduction

The determination of heart rate variability (HRV) consists of measuring the RR intervals of heart beats and calculating their variation 1. During exercise, the increase in intensity results in an increase in heart rate (HR) and reduction in HRV 2. Vagal modulation of HR disappears almost completely at approximately 50 to 60% oxygen uptake at the end of incremental exercise (peak VO2); thereafter, the increase in HR is mainly mediated by sympathetic activation 2. The HRV threshold (HRVT) occurs at this intensity and is characterized as the instant at which the HRV no longer undergoes excessive variation due to the increase in exercise intensity 2. Currently, HRVT can be easily obtained using a commercial heart monitor. Accordingly, HRVT may be useful as a simple, inexpensive tool for prescribing exercise at an appropriate intensity. The validity of HRVT in estimating the ventilatory threshold (VT) has been recently confirmed both in field running and walking tests, with HRVT and VT identified at the same exercise intensity 3,4. Specifically during walking, Dourado et al. 3 demonstrated the usefulness of the incremental shuttle walk test (ISWT) for such purpose in healthy adults. The ISWT was developed to assess the functional exercise capacity of patients with respiratory diseases 5. The test consists of walking in a 10-m flat hallway at progressive velocities imposed by audio signals until exhaustion. The incremental character of the ISWT yields physiological responses closer to those observed in cardiopulmonary exercise testing performed in the laboratory 6. The ISWT was related to a modest learning effect in previous studies involving patients and healthy subjects 6,7. Jurgensen et al. 7 found a statistically significant mean difference of about 40 m between the distance achieved in the first ISWT and that achieved in the second (P = 0.043). This finding underscores the need for familiarization with the ISWT in order to avoid the misinterpretation of functional exercise capacity 8. Walking is a popular form of physical exercise for the conditioning of middle-aged and elderly individuals 9. In some clinical situations, exercise performed at a greater intensity and/or volume is recommended 10,11. Thus, simple strategies for the determination of ideal walking intensity are welcome. In healthy subjects, the VT has been properly estimated using HRVT during the ISWT 3. HRVT assessed during walking constitutes a promising strategy for prescribing exercise in health promotion programs and clinical settings. However, since the ISWT is related to a significant learning effect, the reliability of assessment of HRVT obtained during two subsequent ISWTs should be investigated. The aim of the present study was to evaluate the reliability of HRVT measurement in middle-aged and older adults and to determine the validity of HRVT for estimating VT.

Material and Methods

Participants

Forty participants older than 40 years were invited to participate in the present study. All subjects were free of cardiac and pulmonary disease. Current and former smokers and those with a body mass index (BMI) >35 kg/m2 were excluded from the study. The participants were asked to avoid the use of any substance capable of altering the autonomic modulation of HR (e.g., alcohol). Following enrollment, the participants were informed about the procedures, potential discomfort and risks associated with the study and all gave written informed consent. The present study was approved by the Ethics Committee of Universidade Federal de São Paulo (CEP 1525/08). The participants underwent evaluations related to the protocol in the morning of 2 consecutive days in the same week. Screening and anthropometric evaluations were performed on the first day and cardiopulmonary fitness was evaluated through three ISWTs on the second day, with at least 20-min intervals between tests. After the first walk, the subsequent tests were applied only after cardiopulmonary recovery to basal values so that the exercise-induced sympathetic activity could be minimized.

Incremental shuttle walk test

The ISWT was conducted on the basis of the method described by Singh et al. 5 in a 10-m hallway delimitated by 2 traffic cones at progressive speeds (increase of 0.17 m/s every minute) that was controlled by a series of sounds. The start of the test was indicated by a 3-s sound. Thereafter, short regular beeps indicated the moment that the participants should be turning around the cone. Every minute, the walking velocity increased according to a different sound (more prolonged). When the subject was unable to reach the closest cone (i.e., was >0.5 m from the cone) by the time the signal sounded, the rater ended the test, which also could have been terminated by the subject for any reason. Three tests were performed 20 min apart. The original protocol (12 levels) was slightly modified by extending the test up to 15 levels, since the present study involved only healthy subjects. Distance in meters and walking velocity (WV) in km/h were selected for further analysis. HRV was assessed during the first and second ISWTs and gas exchange analysis was performed in the third test.

Physiologic responses

During the third ISWT, expired gases were collected through a mask and measured using a portable telemetric gas analyzer (K4b2, Cosmed, Italy). The participants breathed through a face mask with minimal dead space (0.30 mL). The gas analyzer (total weight: <1 kg) was attached to the trunk of the participant with straps over his shoulders, allowing free movement. The reference gas, 3-L syringe and delay calibrations were used following manufacturer recommendations. Among other variables, oxygen uptake (VO2), carbon dioxide production (VCO2) and ventilation (VE) were monitored breath-by-breath throughout the test. The data were filtered every 30 s and the arithmetic mean of the last 30 s of the ISWT was used as representative of peak values.

Threshold assessment

To determine VT, the ventilatory equivalents of O2 (VE/VO2) and CO2 (VE/VCO2) were plotted in relation to exercise intensity (i.e., WV) based on the methods described by Wasserman et al. 12. VT was defined as the first non-linear increment in the VE/VO2 curve, while the VE/VCO2 values remained constant. VO2 obtained at VT (VO2VT) was quantified. WV at VO2VT (WV-VT) was also recorded for further analysis. The RR intervals at rest and each 60 s of the ISWT were used to assess HRV. The data were automatically filtered using the Polar ProTrainer 5 software (Polar Electro™, Finland) and then visually inspected. Inadequate heart beats were corrected by interpolating data derived from adjacent normal RR intervals. Any RR interval with a difference greater than 20% of the previous interval was automatically and visually filtered. For the determination of HRVT, the values of the instantaneous variability in the RR intervals (SD1) from the Poincaré plot were plotted against WV. HRVT was assessed in the first stage of exercise in which the difference between the instantaneous variability in the RR intervals (SD1) of two consecutive stages was less than 1 ms and no longer changed significantly. WV at HRVT in the first (WV-HRVT1) and second ISWT (WV-HRVT2) was obtained for further analysis.

Statistical analysis

The individuals were characterized by descriptive analysis of the data. The Student t-test, Pearson's correlation, intraclass correlation coefficient (ICC), and Bland and Altman plot analysis for comparing values obtained in the first and second ISWTs were used to determine the reliability of HRVT. Except for the ICC, the same statistical methods were used for assessing the validity of HRVT in estimating VT regarding the values obtained in the second and third ISWTs. For all statistical tests, P values less than 0.05 were considered to be significant. Statistical analysis was performed using SigmaStat 3.1 (Systat Software Inc.™, USA) and MedCalc version 11.1.1 (MedCalc Software™, Belgium) statistical packages.

Results

It was not possible to measure HRVT in 9 of the 31 participants at the beginning of the study due to mechanical artifacts in the heart monitor (n = 2) and a lack of satisfactory exercise intensity (n = 7), with the peak HR below 80% of the maximum estimated (220 minus age). The general characteristics of these participants (5 females; 58 ± 10 years; 27 ± 4 kg/m2) were not statistically different from those of the remaining sample. Thus, 31 participants composed the final sample of the present study (Table 1), 9 of whom had a BMI between 30 and 35 kg/m2.
Table 1

General characteristics of the individuals studied.

Data are reported as means ± SD. BMI = body mass index; ISWD = incremental shuttle walking distance; WV = walking velocity; VO2 = oxygen uptake.

Data are reported as means ± SD. BMI = body mass index; ISWD = incremental shuttle walking distance; WV = walking velocity; VO2 = oxygen uptake. The ISWT represented high-intensity exercise, as the HR at the end of the test corresponded to 88 ± 10% of the maximum. Mean peak VO2, VCO2 and VE reached 1845 ± 508, 1843 ± 507, and 55 ± 19 mL/min, respectively. HRVT assessment exhibited excellent reliability based on the following results: the difference between WV-HRVT1 and WV-HRVT2 was not significant (median and interquartile range = 4.8; 4.8 to 5.4 vs 4.8; 4.2 to 5.4 km/h); WV-HRVT1 and WV-HRVT2 were strongly correlated (r = 0.84; P < 0.0001); the agreement between WV-HRVT1 and WV-HRVT2 was acceptable (Figure 1); the ICC was high (ICC = 0.92; 95% confidence interval = 0.82-0.96), WV-VT did not differ significantly from WV-HRVT2, and the agreement between WV-VT and WV-HRVT2 was also acceptable (Figure 2).
Figure 1

Agreement between walking velocity (WV) at heart rate variability threshold (HRVT) obtained in the 1st (WV-HRVT1) and 2nd (WV-HRVT2) incremental shuttle walk tests.

Figure 2

Agreement between walking velocity (WV) at heart rate variability threshold (HRVT) and ventilator threshold (VT) obtained in the 2nd (WV-HRVT2) and 3rd (WV-VT) incremental shuttle walk tests.

Discussion

The assessment of HRV in response to exercise is a promising area in sports and exercise science. Accordingly, for its use in assessing functional exercise capacity before and after an intervention, its reliability should be acceptable. The present study describes a simple, inexpensive method for assessment of HRVT during a field-walking test and demonstrates that an important index of HRV (SD1) is reliable in middle-aged and older adults. Despite the learning effect, especially between the first and second ISWT, HRVT remained unchanged and demonstrated excellent reliability in the present study. Although the validity of HRVT against VT has been demonstrated, there are few or no studies in the literature evaluating its reliability. Nevertheless, the present results are in agreement with those of a previously described submaximal exercise. Guijt et al. 13 carried out two measurements of HRV in 26 healthy adults during a cycling test, with a 7-day interval between tests. Reliability was found to be good to excellent for the square root of the mean squared successive difference in RR intervals (RMSSD), with a mean ICC of 0.84. In a study by Tulppo et al. 2, the confidence interval (95%) of the difference for SD1 normalized by RR intervals was ±5.3 at rest and decreased to ±3.3 and ±2.2 during 50 and 75 W of constant exercise, respectively. In fact, some investigators consider reproducibility at rest in both healthy subjects and patients with myocardial infarction to be worse than reproducibility during exercise, as the assessment at rest is potentially influenced by several factors (e.g., time of day, food intake, mental state) 14,15. Nunan et al. 16 used a portable heart monitor to evaluate HRV at rest (10 min) in healthy subjects and found an ICC of 0.86 for RMSSD. Unfortunately, studies with this objective are quite heterogeneous. A review of the literature reveals that the reliability of the short-term assessment of HRV is controversial, with coefficients of variation ranging from 1 to 100%. Similar results have been reported for the ICC and limits of agreement. Thus, it is premature to affirm that the assessment of HRV at rest is a reliable measure and well-controlled studies are necessary to clarify this topic 17. Exercise causes a marked alteration in autonomic function, with a gradual vagal withdrawal followed by sympathetic activation 3. The repeated tests performed in the present study demonstrate that the measurement of the vagal modulation of HR is reliable during an incremental exercise, possibly because the profound effects of the exercise itself on autonomic function minimize the influence of other confounding factors. The results of the present study confirm the validity of HRVT assessment in estimating VT. These findings are consistent with the literature. Karapetian et al. 18 evaluated 24 healthy adults using a cardiopulmonary exercise test (CPET) performed on a stationary cycle and the results showed agreement and a strong correlation (r = 0.89) between VO2 at VT and VO2 at HRVT. Cottin et al. 19 evaluated the correlation between VT and HRVT using the frequency domain of HRV in 11 healthy adults during a CPET on a cycle ergometer and found no significant difference in workload at HRVT and at VT. The correlation between thresholds was intense both in absolute and relative values (r = 0.97 and 0.92, respectively). Few studies have evaluated the usefulness of HRVT to determine VT in field tests. Using the frequency domain of HRV, Cottin et al. 4 evaluated the agreement between HRVT and VT in 12 soccer players during an incremental field running test. VT was evaluated with a telemetric gas analyzer and HRV was obtained using a commercial heart monitor, similar to the methods employed in the present study. There was agreement and strong correlation (R2 = 0.94) between running velocities at HRVT and VT. Dourado et al. 3 found similar results during walking (ISWT), reporting statistically similar walking velocities at HRVT and VT. Comparable results have been recently reported for 14 competitive swimmers 20 during five sets of the 200-m front crawl. The trends of the high-frequency HRV spectral power and its fraction relative to the respiratory sinus arrhythmia were analyzed. In all subjects, an abrupt increase in both indices was observed and associated with the lactate threshold. Lactate thresholds respectively determined from lactate concentrations and HRV indices were similar and strongly correlated. HRVT occurs at vagal withdrawal and, in many cases, coincides with the sustained increase in lactate concentration, which is characteristic of the transition between moderate- and high-intensity exercise 2,12,21. In fact, the lactate threshold is mediated by muscle glycogenolysis and the increase in sympathetic activity during intense exercise causes higher concentrations of catecholamines, which may explain the simultaneous increase in ventilation 22. Considering the peak HR values, the ISWT proved to be a high-intensity exercise. These results reveal the usefulness of the ISWT as a simple way of measuring cardiopulmonary fitness in healthy middle-aged and older adults. Similar results have been obtained with patients with cardiopulmonary diseases 5,6,23,24. Unfortunately, data on the validity of the ISWT for assessing VO2peak in healthy individuals are scarce in the literature. Walking is an important physical activity for health promotion, as it offers fewer physical, social and psychological barriers than other traditional forms of exercise 25. It is socially acceptable and affordable for most people, considering its low cost, relatively low risk and little need for equipment. For sedentary adults, walking represents a moderate intensity physical activity 26. Accordingly, simple, cheap and reliable strategies for prescribing the appropriate amount and intensity of walking, such as that presented here, are useful for increasing the proportion of the population that follows guidelines for physical activity and associated health benefits 9. The main limitation of the present study was the impossibility of assessing HRVT in about 22% of the participants. However, as can be seen in the Results section, the demographic and anthropometric characteristics of these participants were similar to those of the remaining sample. Thus, it is reasonable to affirm that the low intensity of walking during the ISWT was the reason for this situation. In fact, a previous study involving 131 healthy individuals who performed two ISWTs showed a substantial variability in distance and HRmax for males and females 7. Motivation before starting the test plays an important role in the total distance traveled in field walking tests 27 and may explain the impossibility of assessing HRVT in all participants in the present study. In our sample, there were obese participants, with nine participants having a BMI between 30 and 35 kg/m2. This feature does not allow us to say that the sample consisted of only healthy individuals. Furthermore, the sample consisted of middle-aged adults and elderly subjects. The increase in body fat and age can affect the cardiovascular autonomic control. Our results should be used with caution in individuals with different demographic and anthropometric characteristics. The reliability of the assessment of HRVT during an incremental walking test proved to be excellent using instantaneous HRV. Moreover, the ability of the HRVT to estimate VT during walking was demonstrated. Based on these results, the use of the ISWT is suggested for prescribing the appropriate amount and intensity of exercise in walking programs aimed at promoting health. The HRVT also may be useful for quantifying the effects of different interventions on the autonomic modulation of heart rate.
  26 in total

1.  Speed and exercise intensity of recreational walkers.

Authors:  Elaine M Murtagh; Colin A G Boreham; Marie H Murphy
Journal:  Prev Med       Date:  2002-10       Impact factor: 4.018

2.  Estimation of the anaerobic threshold from heart rate variability in an incremental swimming test.

Authors:  Rocco Di Michele; Giorgio Gatta; Antonino Di Leo; Matteo Cortesi; Francesca Andina; Enrico Tam; Mariasole Da Boit; Franco Merni
Journal:  J Strength Cond Res       Date:  2012-11       Impact factor: 3.775

3.  Prescription of walking exercise intensity from the incremental shuttle walk test in people with chronic obstructive pulmonary disease.

Authors:  Rahizan Zainuldin; Martin G Mackey; Jennifer A Alison
Journal:  Am J Phys Med Rehabil       Date:  2012-07       Impact factor: 2.159

4.  [Poor reproducibility of parameters of heart rate variations].

Authors:  H W Breuer; A Skyschally; M Wehr; R Schulz; G Heusch
Journal:  Z Kardiol       Date:  1992-09

5.  Threshold for muscle lactate accumulation during progressive exercise.

Authors:  J Chwalbinska-Moneta; R A Robergs; D L Costill; W J Fink
Journal:  J Appl Physiol (1985)       Date:  1989-06

6.  Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation.

Authors:  S J Singh; M D Morgan; A E Hardman; C Rowe; P A Bardsley
Journal:  Eur Respir J       Date:  1994-11       Impact factor: 16.671

7.  Effect of encouragement on walking test performance.

Authors:  G H Guyatt; S O Pugsley; M J Sullivan; P J Thompson; L Berman; N L Jones; E L Fallen; D W Taylor
Journal:  Thorax       Date:  1984-11       Impact factor: 9.139

8.  Ventilatory and metabolic adaptations to walking and cycling in patients with COPD.

Authors:  P Palange; S Forte; P Onorati; F Manfredi; P Serra; S Carlone
Journal:  J Appl Physiol (1985)       Date:  2000-05

9.  Non-invasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients.

Authors:  Paolo Onorati; Rosa Antonucci; Gabriele Valli; Emanuela Berton; Francesca De Marco; Pietro Serra; Paolo Palange
Journal:  Eur J Appl Physiol       Date:  2003-03-25       Impact factor: 3.078

10.  Development of a shuttle walking test of disability in patients with chronic airways obstruction.

Authors:  S J Singh; M D Morgan; S Scott; D Walters; A E Hardman
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

View more
  6 in total

1.  Cardiorespiratory responses and prediction of peak oxygen uptake during the shuttle walking test in healthy sedentary adult men.

Authors:  Camila D C Neves; Ana Cristina Rodrigues Lacerda; Vanessa K S Lage; Liliana P Lima; Sueli F Fonseca; Núbia C P de Avelar; Mauro M Teixeira; Vanessa A Mendonça
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

2.  Cardiorespiratory fitness assessment and prediction of peak oxygen consumption by Incremental Shuttle Walking Test in healthy women.

Authors:  Liliana Pereira Lima; Hércules Ribeiro Leite; Mariana Aguiar de Matos; Camila Danielle Cunha Neves; Vanessa Kelly da Silva Lage; Guilherme Pinto da Silva; Gladson Salomão Lopes; Maria Gabriela Abreu Chaves; Joyce Noelly Vitor Santos; Ana Cristina Resende Camargos; Pedro Henrique Scheidt Figueiredo; Ana Cristina Rodrigues Lacerda; Vanessa Amaral Mendonça
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

3.  Reliability of the heart rate variability threshold during treadmill exercise.

Authors:  Trent A Hargens; Shane Chambers; Nicholas D Luden; Christopher J Womack
Journal:  Clin Physiol Funct Imaging       Date:  2022-05-19       Impact factor: 2.121

4.  Influence of exercise modality on agreement between gas exchange and heart rate variability thresholds.

Authors:  F A Cunha; R A Montenegro; A W Midgley; F Vasconcellos; P P Soares; P Farinatti
Journal:  Braz J Med Biol Res       Date:  2014-07-08       Impact factor: 2.590

5.  Cardiorespiratory and metabolic responses and reference equation validation to predict peak oxygen uptake for the incremental shuttle waking test in adolescent boys.

Authors:  Andreza L Gomes; Vanessa A Mendonça; Tatiane Dos Santos Silva; Crislaine K V Pires; Liliana P Lima; Alcilene M Gomes; Ana Cristina R Camargos; Camila D C Neves; Ana C R Lacerda; Hércules R Leite
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

6.  Heart rate variability to assess ventilatory thresholds in professional basketball players.

Authors:  Domingo Jesús Ramos-Campo; Jacobo A Rubio-Arias; Vicente Ávila-Gandía; Cristian Marín-Pagán; Antonio Luque; Pedro E Alcaraz
Journal:  J Sport Health Sci       Date:  2016-01-12       Impact factor: 7.179

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.